Skip to main content

Table 1 Focus group discussion and interview demographics

From: Development of an intervention delivered by mobile phone aimed at decreasing unintended pregnancy among young people in three lower middle income countries

 

Tajikistan

n = 78

n (%)

Bolivia

n = 64

n (%)

Palestine

n = 35

n (%)

Number of participants

 FGD1

10

5

10

 FGD2

8

8

Not attended

 FGD3

10

10

Not attended

 FGD4

8

5

4

 FGD5

15

10

3

 FGD6

9

10

7

 FGD7

9

7

7

 FGD8

8

7

Not attended

 Interviews

1

2

4

Age

 15–19

37 (47.4)

26 (40.6)

2 (5.7)

 20–24

37 (47.4)

36 (56.3)

26 (74.3)

 25–30

4 (5.1)

2 (3.1)

5 (14.3)

 Missing

0

0

2 (5.7)

Gender

 Male

33 (42.3)

28 (43.8)

13 (37.1)

 Female

45 (57.7)

36 (56.3)

22 (62.9)

 Missing

0

0

0

Residential area

 City

50 (64.1)

not collectedb

10 (28.6)

 Othera

28 (35.9)

24 (68.6)

 Missing

0

1 (2.9)

Occupation

 Working

20 (25.6)

4 (6.3)

5 (14.3)

 Unemployed

8 (10.3)

0

3 (8.6)

 Full-time parent

1 (1.3)

0

3 (8.6)

 In education or training

49 (62.8)

60 (93.8)

19 (54.3)

 Missing

0

0

5 (14.3)

Pregnancy intention (current)

 Avoid

11 (14.1)

38 (59.4)

13 (37.1)

 Unsure/not avoid/do not mind

29 (37.2)

14 (21.9)

18 (5.1)

 Not sexually active

30 (38.5)

12 (18.8)

2 (5.7)

 Missing

8 (10.3)

0

2 (5.7)

Current method

 Nonec

51 (65.4)

20 (31.3)

13 (37.1)

 Condoms only

22 (28.2)

31 (48.4)

3 (8.6)

 Withdrawal only

0

1 (1.6)

3 (8.6)

 Condoms and withdrawal

2 (2.6)

0

0

 Calendar-based only

0

5 (7.8)

2 (5.7)

 Effective methodd

3 (3.8)

5 (7.8)

8 (22.9)

 Condoms and calendar-based

0

1 (1.6)

1 (2.9)

 Lactational amenorrhea method only

0

0

1 (2.9)

 Condoms and lactational amenorrhea method

0

0

1 (2.9)

 Missing

0

1 (1.6)

3 (8.6)

  1. a’Other’ in Tajikistan is Vahdat, a large town 10 km outside of the capital Dushanbe; ‘Other’ in Palestine is village or refugee camp
  2. bParticipants from El Alto, La Paz or close surrounding areas
  3. cIncludes participants not sexually active
  4. dOral contraceptives, injectables, intra-uterine devices (IUDs), implants, the patch or the ring